期刊文献+

关注抗癫痫药物的标签外用药 被引量:10

原文传递
导出
摘要 抗癫痫药物(antiepileptic drugs,AEDs)是一批由国家食品与药品监督管理局(SFDA)批准的控制癫痫发作的药物。临床使用的AEDs包括传统的AEDs和80年代以后上市的多种新型AEDs。
作者 张月华
出处 《中华儿科杂志》 CAS CSCD 北大核心 2011年第8期564-566,共3页 Chinese Journal of Pediatrics
  • 相关文献

参考文献26

  • 1Chen H, Deshpande AD, Jiang R, et al. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population. Pharmacoepidemiol Drug Saf, 2005,14:629-638.
  • 2Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol, 2007, 62:375- 381.
  • 3Grosso S, Galimberti D, Farnetani MA, et al. Efficacy and safety of topiramate in infants according to epilepsy syndromes. Seizure, 2005,14 : 183- 189.
  • 4Korinthenberg R, Schreiner A. Topiramate in children with West syndrome: a retrospective muhicenter evaluation of 100 patients. J Child Neurol, 2007, 22:302-306.
  • 5Zou LP, Ding CH, Fang F, et al. Prospective study of first-chioce topiramate therapy in newly diagnosed infantile spasms. Clin Neurophannacol, 2006, 29 : 343-349.
  • 6Zhu X, Chen O, Zhang D, et al. A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH. Epilepsy Res, 2011, 93:149-154.
  • 7Kroll-Seqer J, Portilla P, Dulac O, et al. Topiramate in the treatment of highly refractory patients with Dravet syndrome. Neuropediatrics, 2006, 37 : 325-329.
  • 8Perry MS, Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years : a retrospective review. Epilepsia, 2007, 48 : 1123-1127.
  • 9Pina-Garza JE, Nordli Jr DR, Rating D, et al. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia, 2009, 50 : 1141-1149.
  • 10Grosso S, Franzoni E, Coppola G, et al. Efficacy and safety of levetiracetam : An add-on trial in children with refractory epilepsy. Seizure, 2005, 14:248 -253.

共引文献1

同被引文献92

  • 1邹丽萍.儿童抗癫痫药物的合理应用[J].临床药物治疗杂志,2004,2(6):16-20. 被引量:6
  • 2郭金凤,周颖,崔一民.对长期服用含西药的中成药的癫痫患者血药浓度监测[J].中国临床药理学杂志,2006,22(5):369-371. 被引量:5
  • 3昝日增,宋霄宏.《处方管理办法(试行)》新规定与药品说明书之外用药的矛盾及对策[J].中国药房,2006,17(22):1750-1751. 被引量:10
  • 4Banerjee PN, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy: a review. Epilepsy Res, 2009, 85:31- 45.
  • 5Kothare SV, Kaleyias J. The adverse effects of antiepileptic drugs in children. Expert Opin Drug Saf, 2007, 6:251-265.
  • 6LaRoche SM, Helmets SL. The new antiepileptic drugs. JAMA, 2004, 291:605-614.
  • 7Chen H, Deshpande AD, Jiang R, et al. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population. Pharmacoepidemiol Drug Saf, 2005, 14: 629-638.
  • 8Wilton LV, Pearce G, Mann RD. The use of newly marketed drugs in children and adolescents prescribed in general practice. Pharmacoepidemiol Drug Saf, 1999, 8 Suppl 1:37-45.
  • 9Grosso S, Galimberti D, Farnetani MA, et al. Efficacy and safety of topiramate in infants according to epilepsy syndromes. Seizure, 2005, 14:183-189.
  • 10Zhu X, Chen O, Zhang D, et al. A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH. Epilepsy Res, 2011, 93:149-154.

引证文献10

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部